Auteurs
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « Auteurs » - entrée « Yusuf Yazici »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Yusuf Serdar Sakin < Yusuf Yazici < Yusuke Chino  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000291 (2020) Yusuf Yazici [États-Unis]Management of Behçet syndrome.
002610 (2014) Selda Celik [États-Unis] ; Yusuf Yazici [États-Unis] ; Hasan Yazici [Turquie]Are sample sizes of randomized clinical trials in rheumatoid arthritis too large?
002669 (2013) Yusuf Yazici [États-Unis] ; Ismail Simsek [Turquie]Tools for monitoring remission in rheumatoid arthritis: any will do, let's just pick one and start measuring
003525 (2012) Ismail Simsek [Turquie] ; Yusuf YaziciIncomplete reporting of recruitment information in clinical trials of biologic agents for the treatment of rheumatoid arthritis: a review.
003596 (2012) Yusuf Yazici [États-Unis] ; Jeffrey R. Curtis [États-Unis] ; Akgun Ince [États-Unis] ; Herbert Baraf [États-Unis] ; Raymond L. Malamet [États-Unis] ; Lichen L. Teng [États-Unis] ; Arthur Kavanaugh [États-Unis]Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
003868 (2012) Ismail Simsek [Turquie] ; Yusuf Yazici [États-Unis]Incomplete Reporting of Recruitment Information in Clinical Trials of Biologic Agents for the Treatment of Rheumatoid Arthritis: A Review
003874 (2012) Yusuf Yazici [États-Unis] ; Jeffrey R. Curtis [États-Unis] ; Akgun Ince [États-Unis] ; Herbert Baraf [États-Unis] ; Raymond L. Malamet [États-Unis] ; Lichen L. Teng [États-Unis] ; Arthur Kavanaugh [États-Unis]Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
003C62 (2010) Yusuf Yazici [États-Unis] ; Ismail SimsekTreatment options for rheumatoid arthritis beyond TNF-α inhibitors.
003D41 (2010) Allan Gibofsky [États-Unis] ; Yusuf Yazici [États-Unis]Treatment of rheumatoid arthritis: strategies for achieving optimal outcomes
004255 (2007) Vibeke Strand [États-Unis] ; Yusuf YaziciInterleukin-6 inhibition--tolerability profile and clinical implications.
004518 (????) Yusuf Yazici [États-Unis] ; Jeffrey R. Curtis ; Akgun Ince ; Herbert S B. Baraf ; Denise M. Lepley ; Jenny N. Devenport ; Arthur KavanaughEarly effects of tocilizumab in the treatment of moderate to severe active rheumatoid arthritis: a one-week sub-study of a randomised controlled trial (Rapid Onset and Systemic Efficacy [ROSE] Study).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Yusuf Yazici" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "Yusuf Yazici" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    Yusuf Yazici
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021